Wells Fargo & Company Fortress Biotech, Inc. Transaction History

Wells Fargo & Company

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.28 - $0.65 $21,931 - $50,911	78,326 Added 99.25%	157,245 $45,000
Q2 2023 Aug 15, 2023	BUY	$0.49 - $0.82 $7,687 - $12,864	15,688 Added 24.81%	78,919 $43,000
Q1 2023 May 12, 2023	BUY	$0.65 - $1.1 $10,263 - $17,369	15,790 Added 33.28%	63,231 $51,000
Q4 2022 Feb 13, 2023	BUY	$0.48 - $13.5 $7,515 - $211,369	15,657 Added 49.26%	47,441 $31,000
Q3 2022 Nov 14, 2022	BUY	$0.79 - $22.0 $12,329 - $343,354	15,607 Added 96.48%	31,784 $27,000
Q2 2022 Aug 12, 2022	SELL	$0.8 - $1.5 $166,283 - $311,781	-207,854 Reduced 92.78%	16,177 $13,000
Q1 2022 May 16, 2022	SELL	$1.24 - $2.75 $4,472 - $9,919	-3,607 Reduced 1.58%	224,031 $305,000
Q4 2021 Feb 14, 2022	BUY	$2.42 - $3.65 $410,891 - $619,733	169,790 Added 293.51%	227,638 $569,000
Q3 2021 Nov 15, 2021	SELL	$2.82 - $3.7 $265,429 - $348,258	-94,124 Reduced 61.94%	57,848 $186,000
Q2 2021 Aug 16, 2021	BUY	$3.5 - $5.48 $276,671 - $433,188	79,049 Added 108.4%	151,972 $543,000
Q1 2021 May 13, 2021	SELL	$3.16 - $4.89 $250,704 - $387,957	-79,337 Reduced 52.11%	72,923 $257,000
Q4 2020 Feb 09, 2021	BUY	$2.2 - $4.45 $40,702 - $82,329	18,501 Added 13.83%	152,260 $483,000
Q3 2020 Nov 05, 2020	BUY	$2.62 - $4.78 $98,412 - $179,546	37,562 Added 39.05%	133,759 $541,000
Q2 2020 Aug 13, 2020	BUY	$1.83 - $3.16 $175,529 - $303,100	95,918 Added 34379.21%	96,197 $258,000
Q1 2020 May 14, 2020	BUY	$1.14 - $2.96 $318 - $825	279 New	279 $1,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.